Understanding Naegleria fowleri: Diagnostic Challenges, Geographic Distribution, and Emerging Threats

Primary Amoebic Meningoencephalitis (PAM), a rare and often fatal brain infection caused by the free-living amoeba Naegleria fowleri (also known as brain eating amoeba), presents significant clinical challenges due to its rapid progression and limited therapeutic options. The infection is primarily contacted through warm, inadequately chlorinated freshwater environments, leading to severe neurological damage and high mortality rates. Treatment typically involves Amphotericin B (AmB), an antifungal that targets ergosterol in the amoeba’s cell membrane, but its water insolubility and nephrotoxicity limit its effectiveness. Miltefosine (MLT), initially developed for leishmaniasis and breast cancer, shows promise, particularly in combination with AmB and other drugs like Fluconazole (FCZ), Azithromycin (AZM), and Rifampin (RIF), though its variable efficacy highlights the need for further research. In vitro studies have explored drug repurposing, identifying several agents with potential anti-amoebic activity, such as azole antifungals (e.g., Itraconazole and Posaconazole) and other drugs like Auranofin and Pitavastatin. Nanoparticle-based drug delivery systems, including silver (AgNp) and gold nanoparticles (AuNp), have enhanced the efficacy of various drugs by improving CNS penetration and targeting. In vivo studies have demonstrated that Chlorpromazine, an antipsychotic, offers superior survival rates compared to AmB and MLT, while Corifungin shows exceptional promise with a 100% survival rate in preclinical models. To decrease the risk of PAM, one needs to avoid water chlorination and practice other forms of water chlorination, get more information about the illness, and avoid wrong nasal rinsing techniques. Finally, the enhancement in the drug repurposing, nanoparticle conjugation, and prevention has a positive implication, further research is crucial for optimizing the therapeutic management of this severe infection.